Key Insights• South Korea's trauma fixation market is experiencing steady growth, driven by an aging population, rising incidence of road accidents, and increasing prevalence of osteoporosis-related fractures. The market encompasses internal fixation devices as well as external fixation systems used to stabilize broken bones.• South Korea has established a structured trauma care network comprising 17 regional trauma centers operating 24 hours a day, 365 days a year, ensuring that patients with severe trauma from traffic accidents, falls, blunt force injuries, and self-harm can receive immediate surgical treatment. Between 2020 and June 2025, 184,806 patients were treated at these 17 regional trauma centers, with an overall mortality rate of 2.8%.• The country faces a significant trauma burden, with 2,521 traffic fatalities recorded in 2024—a 1.2% decrease from the previous year and the lowest on record. However, South Korea's traffic fatality rate of 5.3 deaths per 100,000 populations still exceeds the OECD average of 4.9. The total economic cost of road traffic accidents in 2023 was estimated at approximately USD 38 billion, reflecting the substantial societal impact of trauma.• The market is witnessing a shift toward technologically advanced solutions, including bioabsorbable materials, 3D-printed implants, and minimally invasive surgical techniques. Major multinational players including Johnson & Johnson, Stryker, and Zimmer Biomet dominate the market, supported by a growing domestic manufacturing base.Market Outlook• According to the research report, "South Korea Trauma Devices Market Research Report, 2031," published by Actual Market Research, the South Korea Trauma Devices Market is expected to reach a market size of more than USD 196.41 Million by 2031.• The South Korea trauma fixation market is poised for steady growth, underpinned by a powerful combination of demographic trends and technological innovation.

An aging population, increasingly susceptible to osteoporotic and fragility fractures, forms a bedrock of sustained demand, alongside a persistent incidence of road accidents and sports injuries. The market is characterized by a dynamic shift toward technologically advanced solutions, with a noticeable trend toward minimally invasive surgical techniques and the adoption of advanced fixation devices such as bioabsorbable materials and 3D-printed implants. • Government initiatives to modernize healthcare infrastructure and support medical device development are further fueling market expansion. Domestic manufacturers are intensifying R&D efforts, while international players are strengthening their presence through partnerships and product launches. The preference for plate and screw systems remains strong, but intramedullary nails and external fixators are gaining traction.Policies • The Ministry of Food and Drug Safety (MFDS) is the central regulatory authority responsible for the safety, efficacy, and market compliance of medical devices in South Korea. Formerly known as the Korea Food and Drug Administration, the MFDS is divided into specialized bureaus, with the Medical Device Safety Bureau specifically handling medical device regulations. The regulatory framework is based on the Medical Device Act, supported by the Enforcement Decree and Enforcement Regulations.• Korean Good Manufacturing Practice (KGMP) certification is mandatory for manufacturers of Class II, III, and IV devices.

Unlike some jurisdictions that rely primarily on ISO 13485 certification, South Korea requires formal KGMP certification issued under MFDS supervision. Foreign manufacturers must appoint a Korean License Holder (KLH) a Korean legal entity that holds the marketing license and takes on legal responsibility for the device in the market.• Recent regulatory updates include the partial amendment of the Enforcement Rules of the Medical Device Act during 2025, with revised Medical Device Standards taking effect from July 4, 2026. The MFDS has also strengthened oversight of medical device safety and is harmonizing with international standards. Class I devices follow a notification pathway with no mandatory KGMP requirement, while Class II devices require notification with documentation. Trauma Burden & Treatment Statistics • South Korea has established a comprehensive trauma care network. The country opened its first regional trauma center in 2014, and 17 regional trauma centers are currently operating nationwide. Between 2020 and June 2025, 184,806 patients were treated at these centers, with an overall mortality rate of 2.8% (5,155 patients).

A nationwide study examining the association between trauma center level and postoperative mortality following trauma surgery in South Korea utilized 2021 data from the Korean National Health Insurance Service.• In 2024, South Korea recorded 2521 traffic fatalities, representing a 1.2% decrease from the previous year and the lowest on record. Traffic fatalities have now declined for 12 consecutive years since 2013. However, South Korea's fatality rate of 5.3 deaths per 100,000 populations still exceeds the OECD average of 4.9. The number of traffic accidents in 2024 was 196,349, a 1.0% decrease from the previous year's 198,296.• A study at a Level 1 trauma center in Korea analyzed trauma volumes and types among orthopedic patients, revealing that the total number of patients decreased significantly from 404 to 150, with non-severe cases decreasing from 361 to 104 while severe cases remained stable. The orthopedic department experienced a decrease in non-severe case numbers with no significant changes in patient or mortality rates post-residential action.Segment AnalysisSouth Korea Trauma Devices Market By Product Type• Internal fixation devices are used in approximately 350,000-500,000 orthopedic trauma procedures annually in South Korea, including plates, screws, intramedullary nails, and locking fixation systems. Major trauma hospitals typically maintain 25-45 implant configurations to treat fractures across different anatomical regions.

A standard internal fixation procedure uses approximately 5-12 implant components, while revision procedures associated with implant failure, infection, or delayed union occur in around 20,000-35,000 cases annually.• External fixation devices support approximately 40,000-60,000 trauma procedures annually in South Korea, mainly for open fractures, severe limb injuries, and temporary stabilization before definitive fixation. Advanced trauma centers typically stock 15-25 external fixation frame systems for emergency use. Each procedure generally requires 4-8 pins or wires, with staged fixation approaches commonly used for complex fractures.• Orthobiologics and synthetic bone grafts are utilized in approximately 60,000-100,000 trauma and reconstruction procedures annually in South Korea. These products are primarily used for fracture non-unions, bone defects, and revision surgeries, with average graft volumes ranging from 5-20 cc per procedure. University hospitals and specialized orthopedic centers perform approximately 400-1,000 graft-assisted trauma procedures annually. South Korea Trauma Devices Market By Surgical Site / Anatomical Location• Lower extremity trauma devices represent the largest segment, supporting approximately 300,000-450,000 procedures annually in South Korea. Femur, tibia, ankle, and hip fractures contribute significantly to trauma admissions, particularly among elderly patients and accident related injuries.

Complex lower limb fixation procedures generally require 5-10 days of hospitalization, with rehabilitation extending 2-12 months depending on injury severity.• Pelvic trauma devices are utilized in approximately 25,000-40,000 surgical interventions annually in South Korea. Pelvic and acetabular fractures generate around 60,000-100,000 trauma admissions annually, commonly linked to traffic accidents, falls, and high impact injuries. Surgical pelvic fixation procedures typically require 10-16 days of hospitalization, followed by long term mobility rehabilitation.• Cranio-maxillofacial trauma devices support approximately 70,000-120,000 facial trauma procedures annually in South Korea. Mandibular, orbital, and mid face fractures represent key treatment areas requiring specialized fixation systems. Titanium plate and screw systems are used in more than 50,000 facial fracture procedures annually, with reconstructive follow-up required for complex trauma cases. South Korea Trauma Devices Market By End User• Hospitals are the primary users of trauma devices in South Korea, supported by approximately 3,000-4,000 hospitals and medical institutions, including specialized trauma centers and tertiary care facilities. These institutions perform the majority of orthopedic trauma surgeries, with major hospitals handling approximately 3,000-8,000 trauma procedures annually.

Advanced hospitals maintain broad implant inventories covering emergency fixation, reconstruction, and revision procedures.• Ambulatory Surgical Centers perform approximately 50,000-90,000 orthopedic trauma-related procedures annually in South Korea, mainly involving minor fracture fixation, implant removal, and outpatient orthopedic procedures. Individual ASCs typically complete 1,000-3,500 orthopedic cases annually. Increasing adoption of outpatient surgical pathways supports faster patient recovery and reduced inpatient requirements.• Orthopedic clinics manage approximately 8-12 million trauma-related consultations annually across South Korea, including fracture evaluation, post-operative monitoring, rehabilitation coordination, and implant follow-up. Individual orthopedic specialists commonly evaluate 40-80 trauma patients per week. Clinics play a significant role in long term recovery management and non-surgical trauma care. South Korea Trauma Devices Market By Material Type• Stainless steel implants are used in approximately 120,000-200,000 trauma fixation procedures annually in South Korea, mainly for standard plates, screws, and routine fracture treatments. Hospitals continue to maintain stainless steel systems due to their durability and established clinical performance.

Implant retention commonly exceeds 5-10 years, with replacement procedures mainly associated with infection, discomfort, or mechanical complications.• Titanium and titanium alloy implants are utilized in approximately 300,000-450,000 trauma procedures annually in South Korea, representing the preferred material for advanced orthopedic fixation. These implants are widely used in long-bone fractures, pelvic reconstruction, and cranio-maxillofacial trauma. Implant retention frequently exceeds 10 years, reducing the requirement for secondary implant removal.• Bioabsorbable materials are used in approximately 15,000-30,000 trauma procedures annually in South Korea, particularly in pediatric fractures, sports injuries, and selected facial trauma applications. These materials gradually degrade over 12-36 months, reducing the need for additional removal procedures. Their adoption is concentrated in university hospitals and specialized orthopedic centers.Considered in this report• Historic Year: 2020• Base year: 2025• Estimated year: 2026• Forecast year: 2031Aspects covered in this report• Trauma Devices Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Internal Fixation Devices• External Fixation Devices• Orthobiologics & Synthetic Bone Grafts• Trauma Surgical Instruments & AccessoriesBy Surgical Site / Anatomical Location• Upper Extremity Trauma Devices• Lower Extremity Trauma Devices• Pelvic Trauma Devices• Cranio-Maxillofacial Trauma DevicesBy End User• Hospitals• Ambulatory Surgical Centers (ASCs)• Orthopedic ClinicsBy Material Type• Stainless Steel• Titanium & Titanium Alloys• Bioabsorbable Materials• Other Materials.